Repro MSC12 iPSC-derived MSCs, Phenol Red-Free
| QTY | Cat # | Size | Unit Price |
|---|---|---|---|
|
| RCRP049 | 1 vial (1 million cells) | $668.00 |
* Prices listed are in USD. Taxes, shipping & handling not included. Contact us for bulk pricing.
Overview
Ready-to-use, Research-grade Human iPSC-derived Mesenchymal Stem Cells (iMSCs)
ReproMSC12 cells were generated from one of our StemRNA™ Clinical Lines, RPC-SKH-44-F19 (established from fibroblasts using the StemRNA Reprogramming Technology).
These cells do not contain Phenol Red, making them ideal for exosome research.
iPSC-derived MSCs, sometimes called iMSCs, offer several advantages over primary MSCs, including a minimally invasive collection process and high proliferative capacity, and they are good candidates for gene editing. Find out more about their potential therapeutic advantages in our recent blog post "The Therapeutic Advantage of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells (iMSCs)".
The corresponding StemRNA Clinical iPSC line, RPC-SKH-44-F19, is also available. Please Contact Us for more information about the clinical iPSCs, or visit our webpage to learn about all of our clinical iPSC and MSC services.
Repro MSC12 cells feature:
- Immediate thawing into Phenol Red-free MSC NutriStem XF Culture medium (Cat. No. 01-0007) on NutriCoat™ Attachment Solution (Cat. No. 05-0063) with easy conversion to other standard MSC Media.
- The possibility of saving significant time compared to isolating your own primary MSCs.
| Cat. No.: | RCRP052 |
| Mutation: | B2M/CIITA double knockout |
| Mutation validation: |
DNA Sequencing, B2M expression (flow) |
| Parent Clone ID: |
StemRNA Clinical iPSC Clone LLF-34-F3 |
| Donor Blood Type: |
O positive |
| Donor Race: | Caucasian |
| Donor Sex: | Female |
| Donor Age: | 22 |
| Reprogramming Technology: | StemRNA Clinical Reprogramming Technology |
| Tissue Source: | Skin (Fibroblasts) |
| Karyotype: | Normal (46 XX) |
| Microbiology: | Negative for bacteria, virus, and mycoplasma |